Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$1.64B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$1.1B |
| 3 |
Apple
AAPL
|
+$928M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$804M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$765M |
Top Sells
| 1 |
CRH
CRH
|
+$771M |
| 2 |
Bank of America
BAC
|
+$711M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$536M |
| 4 |
NVIDIA
NVDA
|
+$481M |
| 5 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$417M |
Sector Composition
| 1 | Technology | 29.49% |
| 2 | Financials | 11.51% |
| 3 | Consumer Discretionary | 10.99% |
| 4 | Healthcare | 10.02% |
| 5 | Communication Services | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Sight Sciences
SGHT
$190M
| $153K | ﹤0.01% |
29,725
+20,081
| +208% | +$103K |
|
3477
Smith-Midland
SMID
$221M
| $152K | ﹤0.01% |
+3,840
| New | +$152K |
|
3478
Riskified
RSKD
$732M
| $151K | ﹤0.01% |
32,149
-12,458
| -28% | -$58.5K |
|
3479
Real Estate Select Sector SPDR Fund
XLRE
$7.84B
| $151K | ﹤0.01% |
3,756
-124,914
| -97% | -$5.02M |
|
|
TBNK
3480
DELISTED
Territorial Bancorp Inc.
TBNK
| $150K | ﹤0.01% |
13,435
| – | – |
|
3481
BioAtla
BCAB
$45.5M
| $149K | ﹤0.01% |
60,893
+52,950
| +667% | +$130K |
|
3482
Shell
SHEL
$209B
| $149K | ﹤0.01% |
2,265
-402,727
| -99% | -$26.5M |
|
3483
Sasol
SSL
$4.53B
| $149K | ﹤0.01% |
14,994
-60,749
| -80% | -$604K |
|
|
TGAN
3484
DELISTED
Transphorm, Inc. Common Stock
TGAN
| $148K | ﹤0.01% |
40,519
+35,006
| +635% | +$128K |
|
3485
TELA Bio
TELA
$64.2M
| $147K | ﹤0.01% |
22,270
+19,341
| +660% | +$128K |
|
3486
Vanguard Mid-Cap Growth ETF
VOT
$17.9B
| $147K | ﹤0.01% |
670
| – | – |
|
3487
Cue Biopharma
CUE
$58.8M
| $146K | ﹤0.01% |
55,529
+43,516
| +362% | +$114K |
|
|
SII
3488
Sprott
SII
$1.78B
| $146K | ﹤0.01% |
4,281
-35
| -0.8% | -$1.19K |
|
3489
Neuropace
NPCE
$331M
| $144K | ﹤0.01% |
13,971
+3,132
| +29% | +$32.3K |
|
3490
ESS Tech
GWH
$20.5M
| $143K | ﹤0.01% |
8,367
+7,342
| +716% | +$125K |
|
|
MITT
3491
AG Mortgage Investment Trust
MITT
$247M
| $143K | ﹤0.01% |
22,507
+6,940
| +45% | +$44.1K |
|
3492
LanzaTech
LNZA
$45.5M
| $142K | ﹤0.01% |
283
+193
| +214% | +$96.8K |
|
|
OMGA
3493
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $142K | ﹤0.01% |
46,973
+29,013
| +162% | +$87.7K |
|
3494
DLH Holdings
DLHC
$79.1M
| $140K | ﹤0.01% |
8,881
+6,837
| +334% | +$108K |
|
3495
Latham Group
SWIM
$929M
| $140K | ﹤0.01% |
53,176
+46,673
| +718% | +$123K |
|
3496
Assertio
ASRT
$77.5M
| $139K | ﹤0.01% |
129,069
+106,079
| +461% | +$114K |
|
3497
CoreCard
CCRD
$213M
| $139K | ﹤0.01% |
+10,076
| New | +$139K |
|
3498
SKYX Platforms
SKYX
$133M
| $139K | ﹤0.01% |
86,879
+75,037
| +634% | +$120K |
|
3499
Rallybio
RLYB
$24.7M
| $138K | ﹤0.01% |
57,479
+51,326
| +834% | +$123K |
|
3500
Cartesian Therapeutics
RNAC
$259M
| $138K | ﹤0.01% |
6,672
+4,683
| +235% | +$96.9K |
|